Hashem El-Serag
#35,278
Most Influential Person Now
American medical researcher
Hashem El-Serag's AcademicInfluence.com Rankings
Hashem El-Seraglaw Degrees
Law
#696
World Rank
#923
Historical Rank
#403
USA Rank
Common Law
#4
World Rank
#4
Historical Rank
#3
USA Rank
International Law
#45
World Rank
#68
Historical Rank
#15
USA Rank
Download Badge
Law
Hashem El-Serag's Degrees
- Doctorate Medicine Cairo University
Why Is Hashem El-Serag Influential?
(Suggest an Edit or Addition)According to Wikipedia, Hashem B. El-Serag is a Palestinian-American physician and medical researcher best known for his research in liver cancer, hepatocellular carcinoma and the hepatitis C virus. He serves as the Margaret M. and Albert B. Alkek Chairman of the Department of Medicine at Baylor College of Medicine as well as the Director of the Texas Medical Center Digestive Disease Center. El-Serag previously served as president of the American Gastroenterological Association and Editor-in-Chief of Clinical Gastroenterology and Hepatology.
Hashem El-Serag's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (2007) (4021)
- Rising incidence of hepatocellular carcinoma in the United States. (1999) (2957)
- Epidemiology of viral hepatitis and hepatocellular carcinoma. (2012) (2806)
- Epidemiology of gastro-oesophageal reflux disease: a systematic review (2005) (1790)
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (2017) (1514)
- Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review (2013) (1368)
- Diagnosis and treatment of hepatocellular carcinoma. (2008) (1322)
- Hepatocellular carcinoma. (2011) (1174)
- The epidemiology of cholangiocarcinoma. (2004) (1149)
- Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. (2004) (1136)
- Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications (2005) (1133)
- Hepatocellular carcinoma: recent trends in the United States. (2004) (980)
- The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update (2003) (970)
- Epidemiology of hepatocellular carcinoma: consider the population. (2013) (924)
- Risk factors for cholangiocarcinoma (2011) (819)
- Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature (2011) (783)
- The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. (2006) (771)
- Epidemiology and Management of Hepatocellular Carcinoma. (2019) (684)
- The Epidemiology of Malignant Gastrointestinal Stromal Tumors: An Analysis of 1,458 Cases from 1992 to 2000 (2005) (670)
- Hepatocellular carcinoma: an epidemiologic view. (2002) (666)
- Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study (2005) (657)
- Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. (2012) (651)
- Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? (2004) (635)
- Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. (2017) (610)
- Burden of liver disease in the United States: Summary of a workshop (2002) (603)
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention (2020) (554)
- Burden of Gastric Cancer. (2020) (552)
- The changing pattern of epidemiology in hepatocellular carcinoma. (2010) (519)
- Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. (2005) (517)
- Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? (2014) (516)
- Obesity Is an Independent Risk Factor for GERD Symptoms and Erosive Esophagitis (2005) (510)
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database (2011) (503)
- Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. (2005) (502)
- Obesity: a challenge to esophagogastric junction integrity. (2006) (497)
- Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. (2004) (494)
- Epidemiology of Hepatocellular Carcinoma (2020) (486)
- Hepatocellular carcinoma and hepatitis C in the United States (2002) (455)
- Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. (2007) (449)
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. (2016) (445)
- Risk factors for the rising rates of primary liver cancer in the United States. (2000) (437)
- Time trends of gastroesophageal reflux disease: a systematic review. (2007) (418)
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. (2015) (415)
- Epidemiology of hepatocellular carcinoma in USA (2007) (413)
- Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. (2008) (401)
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. (2018) (394)
- Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. (2008) (393)
- Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. (2011) (390)
- Opposing time trends of peptic ulcer and reflux disease (1998) (387)
- Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States (2010) (380)
- Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma (2017) (364)
- Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States (2001) (361)
- Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. (1997) (360)
- Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States (2013) (358)
- Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus (2004) (351)
- Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. (2017) (342)
- AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 (2020) (332)
- Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. (2007) (329)
- The epidemiology of obesity. (2010) (325)
- Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. (2010) (321)
- Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection (2016) (318)
- Esophageal carcinoma. (2014) (312)
- Global epidemiology and burden of HCV infection and HCV-related disease (2017) (310)
- Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. (2013) (295)
- Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus–Infected Veterans in the United States (2011) (294)
- Extrahepatic manifestations of hepatitis C among United States male veterans (2002) (284)
- The association between gastro-oesophageal reflux disease and asthma: a systematic review (2007) (274)
- Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population‐based study of U.S. veterans (2009) (273)
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV (2014) (266)
- Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA (2002) (263)
- The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans (2001) (260)
- Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population‐based study (2004) (259)
- Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. (2019) (259)
- Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. (2009) (258)
- Gastroesophageal reflux among different racial groups in the United States. (2004) (256)
- Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: A Hospital-Based Case–Control Study (2007) (255)
- Psychiatric disorders among veterans with hepatitis C infection. (2002) (250)
- Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. (2015) (250)
- Lifestyle Intervention in Gastroesophageal Reflux Disease. (2016) (246)
- The Association Between Obesity and GERD: A Review of the Epidemiological Evidence (2008) (242)
- Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies (2010) (237)
- Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis (2013) (233)
- Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers (2004) (233)
- AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic (2020) (228)
- Symptomatic reflux disease: the present, the past and the future (2014) (225)
- Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. (2006) (222)
- Epidemiology of hepatocellular carcinoma. (2001) (220)
- Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. (2015) (218)
- Abdominal Obesity and the Risk of Barrett's Esophagus (2005) (217)
- A Comparison of Trends in the Incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in the United States (2006) (206)
- Distribution and Manifestations of Inflammatory Bowel Disease in Asians, Hispanics, and African Americans: A Systematic Review (2009) (197)
- Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial (2001) (194)
- The Prevalence and Risk Factors of Functional Dyspepsia in a Multiethnic Population in the United States (2004) (193)
- Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. (2010) (190)
- Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. (2001) (188)
- Obesity increases oesophageal acid exposure (2006) (186)
- Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis (2003) (175)
- Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? (2003) (172)
- Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. (2004) (171)
- Racial disparities and socioeconomic status in association with survival in a large population‐based cohort of elderly patients with colon cancer (2007) (170)
- Corpus gastritis is protective against reflux oesophagitis (1999) (168)
- Is There a True “shift” to the Right Colon in the Incidence of Colorectal Cancer? (2003) (166)
- AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review. (2020) (163)
- Clinical epidemiology and natural history of gastroesophageal reflux disease. (1999) (160)
- Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. (2007) (160)
- Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs (2000) (159)
- Colonic mucosal abnormalities associated with oral sodium phosphate solution. (1996) (158)
- Natural History of Pediatric-onset Inflammatory Bowel Disease: A Systematic Review (2012) (158)
- Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States (2018) (158)
- Medication usage and the risk of neoplasia in patients with Barrett's esophagus. (2009) (157)
- Diabetes increases the risk of acute hepatic failure. (2002) (154)
- Gastric Cancer as Preventable Disease (2017) (153)
- Role of obesity in GORD-related disorders (2008) (152)
- The Effect of HIV Coinfection on the Risk of Cirrhosis and Hepatocellular Carcinoma in U.S. Veterans with Hepatitis C (2005) (152)
- Complications of pediatric EGD: a 4-year experience in PEDS-CORI. (2007) (150)
- A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. (2014) (150)
- National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. (2005) (149)
- Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents (2020) (147)
- Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer (2001) (144)
- Anthropometric correlates of intragastric pressure (2006) (144)
- Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. (2015) (142)
- The Role of Hepatitis C in Hepatocellular Carcinoma: A Case Control Study Among Egyptian Patients (2001) (137)
- Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. (2008) (137)
- Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis (2001) (132)
- Rising Prevalence of Hepatitis C Virus Infection Among Patients Recently Diagnosed With Hepatocellular Carcinoma in the United States (2002) (129)
- Associations between different forms of gastro-oesophageal reflux disease (1997) (129)
- The Impact of Curative Intent Surgery on the Survival of Pancreatic Cancer Patients: A U.S. Population-Based Study (2007) (127)
- Surveillance for hepatocellular carcinoma: in whom and how? (2011) (127)
- Gastroesophageal Reflux and Asthma in Children: A Systematic Review (2010) (126)
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease (2020) (125)
- Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study (2013) (125)
- Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. (2016) (124)
- The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. (2012) (123)
- Epidemiology of hepatocellular carcinoma in Hispanics in the United States. (2007) (123)
- Missed Opportunities to Initiate Endoscopic Evaluation for Colorectal Cancer Diagnosis (2009) (120)
- Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. (2008) (120)
- Systematic review: the association between symptomatic response to proton pump inhibitors and health‐related quality of life in patients with gastro‐oesophageal reflux disease (2011) (119)
- Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort. (2016) (119)
- Burden of Pancreatic Cancer-From Epidemiology to Practice. (2020) (116)
- Risk Factors for the Severity of Erosive Esophagitis in Helicobacter pylori -Negative Patients with Gastroesophageal Reflux Disease (2002) (115)
- Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. (2010) (114)
- An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. (2010) (114)
- Women have Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. (2020) (112)
- Oral contraception and the risk of hepatocellular carcinoma. (2007) (110)
- Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting (2015) (109)
- Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus (2014) (108)
- The epidemic of esophageal adenocarcinoma. (2002) (107)
- Diagnostic Performance of Measurement of Fecal Elastase‐1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta‐analysis (2018) (106)
- AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic (2020) (104)
- Esophageal carcinoma. (2015) (103)
- Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B. (2018) (101)
- Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA (2011) (100)
- Age at Onset of GERD Symptoms Predicts Risk of Barrett's Esophagus (2013) (100)
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. (2021) (99)
- Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review. (2016) (99)
- Gaps in the achievement of effectiveness of HCV treatment in national VA practice. (2012) (97)
- Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance (2017) (96)
- Sleep duration and incidence of colorectal cancer in postmenopausal women (2013) (95)
- Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. (2017) (95)
- Insurance status and treatment candidacy of hepatitis C patients: Analysis of population‐based data from the United States (2011) (94)
- The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. (2006) (94)
- The Association Between Barrett’s Esophagus and Helicobacter pylori Infection: A Meta‐Analysis (2012) (92)
- Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs Health Care System (2018) (91)
- Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux (2017) (89)
- Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus‐infected patients (2013) (88)
- Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. (2015) (87)
- Evaluation for liver transplantation: Adherence to AASLD referral guidelines in a large veterans affairs center (2005) (87)
- Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? (2003) (87)
- Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. (2013) (87)
- Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002 (2008) (87)
- Association Between Hepatitis C Infection and Other Infectious Diseases: A Case For Targeted Screening? (2003) (86)
- Childhood GERD is a Risk Factor for GERD in Adolescents and Young Adults (2004) (86)
- The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. (2006) (83)
- Systematic review: the epidemiology of gastro‐oesophageal reflux disease in primary care, using the UK General Practice Research Database (2009) (83)
- Importance of Patient, Provider, and Facility Predictors of Hepatitis C Virus Treatment in Veterans: A National Study (2011) (83)
- Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. (2015) (82)
- Fundoplication and the Risk of Esophageal Cancer in Gastroesophageal Reflux Disease: A Veterans Affairs Cohort Study (2005) (81)
- Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. (2019) (81)
- Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. (2005) (80)
- Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification (2014) (80)
- Utilization of screening for hepatocellular carcinoma in the United States. (2008) (80)
- Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life. (2003) (79)
- Racial Differences in the Progression to Cirrhosis and Hepatocellular Carcinoma in HCV-Infected Veterans (2014) (79)
- Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. (2006) (78)
- Surgical Volume and Long-Term Survival Following Surgery for Colorectal Cancer in the Veterans Affairs Health-Care System (2004) (78)
- Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness Analysis (2000) (78)
- Helicobacter pylori-Negative Gastritis: Prevalence and Risk Factors (2013) (77)
- The Epidemiology of Hepatocellular Carcinoma in the USA (2019) (76)
- Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. (2007) (76)
- Accuracy of Diagnostic Codes for Identifying Patients with Ulcerative Colitis and Crohn’s Disease in the Veterans Affairs Health Care System (2014) (76)
- Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. (2019) (75)
- Prevalence of Endoscopic Findings of Erosive Esophagitis in Children: A Population-based Study (2008) (75)
- Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. (2014) (74)
- Utilization and Outcomes of Palliative Therapy for Hepatocellular Carcinoma: A Population-based Study in the United States (2012) (74)
- Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits (2002) (71)
- Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction (2013) (71)
- Underdiagnosis of Lynch syndrome involves more than family history criteria. (2010) (71)
- A multibiomarker risk score helps predict risk for Barrett's esophagus. (2014) (69)
- Noncardia Gastric Adenocarcinoma Remains an Important and Deadly Cancer in the United States: Secular Trends in Incidence and Survival (2006) (69)
- Dietary quality and the colonic mucosa-associated gut microbiome in humans. (2019) (68)
- Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System (2003) (68)
- Higher serum testosterone is associated with increased risk of advanced hepatitis C–related liver disease in males (2012) (67)
- Psychosocial Factors Are the Most Common Contraindications for Antiviral Therapy at Initial Evaluation in Veterans With Chronic Hepatitis C (2004) (67)
- Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. (2015) (67)
- Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia (2016) (67)
- Epidemiology of Non-Erosive Reflux Disease (2008) (67)
- Menopausal hormone therapy and the risk of esophageal and gastric cancer (2017) (66)
- Natural history of irritable bowel syndrome (2004) (66)
- Using a Multifaceted Approach to Improve the Follow-Up of Positive Fecal Occult Blood Test Results (2009) (66)
- Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus‐infected patients (2014) (66)
- Early outpatient follow‐up and 30‐day outcomes in patients hospitalized with cirrhosis (2016) (66)
- Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma (2011) (64)
- The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? (2003) (64)
- Trauma history and risk of the irritable bowel syndrome in women veterans (2010) (63)
- Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. (2011) (63)
- Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. (2000) (62)
- Characteristics of intestinal metaplasia in the gastric cardia (1999) (62)
- A research agenda for curing chronic hepatitis B virus infection (2018) (61)
- Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection (2011) (61)
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. (2022) (60)
- Statins and the Risk of Colorectal Carcinoma: A Nested Case–Control Study in Veterans With Diabetes (2009) (59)
- Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta‐analysis (2017) (58)
- Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. (1997) (58)
- Physical and Psychosocial Contributors to Quality of Life in Veterans With Hepatitis C Not on Antiviral Therapy (2005) (57)
- Adapting the Rx-Risk-V for Mortality Prediction in Outpatient Populations (2006) (57)
- Complications of pediatric colonoscopy: a five-year multicenter experience. (2008) (55)
- Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. (2001) (55)
- Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. (2012) (55)
- The Incidence and Prevalence of Inflammatory Bowel Disease Among U.S. Veterans: A National Cohort Study (2013) (53)
- Gastric Microbiota in Helicobacter pylori-Negative and -Positive Gastritis Among High Incidence of Gastric Cancer Area (2019) (53)
- Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. (2018) (52)
- Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. (2002) (52)
- OOutcomes of Colorectal Cancer in the United States: No Change in Survival (1986–1997) (2003) (52)
- Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. (2016) (52)
- Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey (2019) (51)
- The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans (2015) (51)
- Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: Effect of patient and nonpatient factors (2013) (51)
- Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications (2018) (50)
- Validation of Case Finding Algorithms for Hepatocellular Cancer From Administrative Data and Electronic Health Records Using Natural Language Processing (2016) (50)
- Postoperative 30-day Mortality Following Surgical Resection for Colorectal Cancer in Veterans: Changes in the Right Direction (2005) (49)
- Outcomes of surgical fundoplication in children. (2004) (49)
- Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failuare. (2020) (48)
- No Significant Effects of Smoking or Alcohol Consumption on Risk of Barrett’s Esophagus (2013) (48)
- Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. (2011) (46)
- Epidemiology of Gastroesophageal Reflux Disease (1997) (46)
- Leadership During Crisis: Lessons and Applications from the COVID-19 Pandemic (2020) (45)
- Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study. (2015) (45)
- The Impact of HIV Viral Control on the Incidence of HIV-Associated Anal Cancer (2013) (45)
- Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium (2018) (45)
- Endoscopic and Surgical Therapy for Intrahepatic Cholangiocarcinoma in the United States: A Population-based Study (2007) (44)
- Celiac Sprue Among US Military Veterans (Associated Disorders and Clinical Manifestations) (1999) (44)
- Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection (2017) (44)
- Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013 (2017) (43)
- Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. (2012) (43)
- The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992–2006) (2011) (43)
- Reducing referral delays in colorectal cancer diagnosis: is it about how you ask? (2010) (43)
- Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. (2009) (42)
- Obesity and disease of the esophagus and colon. (2005) (41)
- Clinical Manifestations of Helicobacter pylori–Negative Gastritis (2017) (41)
- The effects of sustained virological response to direct‐acting anti‐viral therapy on the risk of extrahepatic manifestations of hepatitis C infection (2019) (41)
- Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system (2004) (40)
- Lessons From Using Culture‐Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection (2018) (40)
- Systemic review: Natural history of irritable bowel syndrome. (2004) (40)
- Efficacy, effectiveness, and comparative effectiveness in liver disease (2010) (39)
- Time-trends in gastroprotection with NSAIDs (2010) (39)
- Secular Trends in the Use, Quality, and Outcomes of Gastrectomy for Noncardia Gastric Cancer in the United States (2007) (39)
- Epidemiology and outcomes of hepatitis C infection in elderly US Veterans (2016) (38)
- Statin use is associated with a decreased risk of Barrett's esophagus. (2014) (38)
- Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. (2007) (38)
- Utilization of Screening for Hepatocellular Carcinoma in the United States (2007) (38)
- The Quality of Care Provided to Patients With Varices in the Department of Veterans Affairs (2014) (38)
- Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. (2015) (38)
- Statin Therapy and Serum Transaminases Among a Cohort of HCV-Infected Veterans (2009) (38)
- Report on a single‐topic conference on “Chronic Viral Hepatitis–Strategies to Improve Effectiveness of Screening and Treatment” (2012) (38)
- Outcome of erosive reflux esophagitis after Nissen fundoplication (1999) (37)
- Geographic variation within the United States in the incidence of hepatocellular carcinoma. (2003) (37)
- The Extent and Determinants of Prescribing and Adherence With Acid-Reducing Medications: A National Claims Database Study (2009) (37)
- Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon (2019) (36)
- Obesity and hepatocellular carcinoma: Hype and reality (2014) (36)
- Determinants of Medical System Delay in the Diagnosis of Colorectal Cancer Within the Veteran Affairs Health System (2010) (35)
- Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease (2021) (35)
- Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. (2001) (35)
- The big burden of obesity. (2009) (34)
- Increased risk of hepatocellular carcinoma after cholecystectomy (2011) (34)
- Risk Factors for Barrett’s Esophagus Compared Between African Americans and Non-Hispanic Whites (2014) (34)
- Oral Bisphosphonate Prescriptions and the Risk of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus (2010) (34)
- Barrett's Esophagus Suspected at Endoscopy but No Specialized Intestinal Metaplasia on Biopsy, What's Next? (2014) (34)
- Gene expression in Barrett's esophagus: Laser capture versus whole tissue (2009) (34)
- Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial (2018) (33)
- Outcomes of colorectal cancer in the United States (2003) (33)
- Cost-Effectiveness and Diagnostic Effectiveness Analyses of Multiple Algorithms for the Diagnosis of Lynch Syndrome (2014) (33)
- Comparison of endoscopic ultrasound guided 22-gauge core needle with standard 25-gauge fine-needle aspiration for diagnosing solid pancreatic lesions (2015) (32)
- Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir (2018) (32)
- α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it. (2013) (32)
- Real‐world effectiveness of elbasvir/grazoprevir In HCV‐infected patients in the US veterans affairs healthcare system (2018) (32)
- Routine polypectomy for colorectal polyps and ablation for Barrett's esophagus are intellectually the same. (2011) (31)
- Automated Identification of Surveillance Colonoscopy in Inflammatory Bowel Disease Using Natural Language Processing (2013) (31)
- Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell‐like hyperplasia (2011) (31)
- Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation (2019) (31)
- Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study (2006) (31)
- The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. (2015) (31)
- Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes (2020) (30)
- Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight (2022) (30)
- Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. (2017) (30)
- Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett’s Esophagus (2016) (30)
- Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality (2020) (29)
- Incidence and Survival of Colorectal Cancer Among Hispanics in the United States: A Population-Based Study (2013) (29)
- Patient-Reported Attributions for Missed Colonoscopy Appointments in Two Large Healthcare Systems (2016) (29)
- The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A retrospective cohort Study of united States Veterans (2018) (29)
- Recent advances in basic science EPIDEMIOLOGY OF GASTRO-OESOPHAGEAL REFLUX DISEASE : A SYSTEMATIC REVIEW (2005) (29)
- Fulminant herpes colitis in a patient with Crohn's disease. (1996) (28)
- Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis (2018) (28)
- Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. (2005) (27)
- Hepatocellular carcinoma associated with autoimmune hepatitis. (2003) (27)
- Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans with Cirrhosis. (2019) (27)
- Ethnic variations in the occurrence of gastroesophageal cancers. (1999) (26)
- Barrett's esophagus in children and adolescents without neurodevelopmental or tracheoesophageal abnormalities: a prospective study. (2011) (26)
- Fat Mass by Bioelectrical Impedance Analysis is not Associated With Increased Risk of Barrett Esophagus (2014) (26)
- Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus. (2012) (26)
- Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality. (2019) (26)
- Systematic review with meta‐analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients (2020) (26)
- Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. (2020) (25)
- Empirical Therapy versus Diagnostic Tests in Gastroesophageal Reflux Disease (A Medical Decision Analysis) (1998) (25)
- Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett’s esophagus (2013) (25)
- Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis* (2012) (24)
- The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States (2004) (24)
- The Incidence of Esophageal Adenocarcinoma in a National Veterans Cohort With Barrett’s Esophagus (2014) (24)
- The Utility of Evaluating Low Serum Albumin Gradient Ascites in Patients With Cirrhosis (2009) (24)
- Human papillomavirus and the risk of Barrett's esophagus. (2013) (24)
- The Use of Cytokeratin Stain to Distinguish Barrett’s Esophagus from Contiguous Tissues: A Systematic Review (2007) (24)
- Is there a race-based disparity in the survival of veterans with HIV? (2006) (24)
- Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. (2009) (24)
- Preparing for the NASH Epidemic: A Call to Action. (2021) (23)
- Artificial intelligence in gastroenterology: A state-of-the-art review (2021) (23)
- Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop (2017) (23)
- Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study (2019) (23)
- Sex and Racial Disparity in Incidence of Esophageal Adenocarcinoma: Observations and Explanations. (2016) (23)
- GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis (2021) (23)
- Hepatocellular carcinoma surveillance: The road ahead (2017) (23)
- Opportunities for Preventing Esophageal Adenocarcinoma (2016) (23)
- Inflammatory Bowel Disease Characteristics and Treatment in Hispanics and Caucasians (2011) (22)
- Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey (2017) (22)
- Cholangiocarcinoma: the “other” liver cancer on the rise (2002) (22)
- Preparing for the NASH epidemic: A call to action. (2021) (22)
- Translational research: the study of community effectiveness in digestive and liver disorders. (2007) (22)
- Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey (2013) (22)
- Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus. (2014) (22)
- Postreferral Colonoscopy Delays in Diagnosis of Colorectal Cancer: A Mixed-Methods Analysis (2012) (22)
- Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. (2016) (21)
- Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma. (2009) (21)
- Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. (2003) (21)
- The epidemic of esophageal adenocarcinoma (2003) (21)
- Choosing Wisely and the perceived drivers of endoscopy use. (2013) (20)
- Temporal Trends in New and Recurrent Esophageal Strictures in Department of Veterans Affairs (2006) (20)
- Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making. (2013) (20)
- Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing (2017) (20)
- Prediction Models for Gastrointestinal and Liver Diseases: Too Many Developed, Too Few Validated. (2016) (20)
- Prior Diagnosis of Barrett’s Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival (2018) (20)
- Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings from Texas Hepatocellular Carcinoma Consortium Cohort. (2020) (20)
- Rational screening approaches for HCC in NAFLD patients. (2021) (19)
- Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study (2019) (19)
- Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. (2014) (19)
- Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women’s Health Initiative Study (2018) (18)
- The Performance of Process Measures in Hepatitis C (2012) (18)
- Patient Experiences with Surveillance Endoscopy: A Qualitative Study (2014) (18)
- Surveillance for Hepatocellular Carcinoma: Development and Validation of an Algorithm to Classify Tests in Administrative and Laboratory Data (2010) (18)
- The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC). A Phase 3 Biomarker Study in the United States. (2022) (18)
- Surveillance in Barrett's esophagus: lessons from behavioral economics. (2009) (18)
- WNT Signaling Pathway Gene Polymorphisms and Risk of Hepatic Fibrosis and Inflammation in HCV-Infected Patients (2013) (18)
- Gastric microbiota and Helicobacter pylori in Indonesian population (2020) (18)
- Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males. (2014) (18)
- Missed Opportunities for Screening and Surveillance of Barrett’s Esophagus in Veterans with Esophageal Adenocarcinoma (2018) (18)
- Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists (2018) (18)
- Economic aspects of endoscopic screening for intestinal precancerous conditions. (1997) (18)
- Assessment of disease specific knowledge and health-related quality of life among United States military veterans with inflammatory bowel disease. (2015) (17)
- A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women (2019) (17)
- Gastro-oesophageal reflux disease (2021) (17)
- Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma. (2012) (17)
- External Validation of the Michigan Barrett's Esophagus Prediction Tool (2017) (17)
- The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett’s Esophagus (2017) (17)
- Writing and publishing scientific papers. (2012) (17)
- Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness. (2014) (17)
- Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age–Period–Cohort Analysis (2019) (17)
- Process of care for hepatitis C infection is linked to treatment outcome and virologic response. (2012) (17)
- Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population (2019) (16)
- 458 The Rising Incidence of Hepatocellular Carcinoma in the United States: an Update (2012) (16)
- Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System. (2004) (16)
- The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. (2019) (16)
- Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. (2007) (16)
- Factors That Contribute to Indeterminate Results From the QuantiFERON‐TB Gold In‐Tube Test in Patients With Inflammatory Bowel Disease (2017) (16)
- Surveillance for hepatocellular carcinoma: can we focus on the mission? (2015) (16)
- Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age. (2016) (16)
- Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis (2020) (15)
- Surveillance for Hepatocellular Carcinoma: Long Way to Achieve Effectiveness (2012) (15)
- A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study (2018) (15)
- Oral Bisphosphonates and the Risk of Barrett's Esophagus: Case–Control Analysis of US Veterans (2013) (15)
- European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners (2020) (15)
- Management of the Single Liver Nodule in a Cirrhotic Patient: A Decision Analysis Model (2005) (15)
- Risk factors for HCC in contemporary cohorts of patients with cirrhosis (2022) (14)
- Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus. (2017) (14)
- Prevalence of Barrett's esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans. (2020) (14)
- Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018. (2020) (14)
- Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review (2008) (14)
- Use and yield of endoscopy in patients with uncomplicated gastroesophageal reflux disorder. (2014) (13)
- Outcome of erosive reflux esophagitis after Nissen fundoplication. (1999) (13)
- Long-term follow up of patients with obscure gastrointestinal bleeding examined with video capsule endoscopy (2018) (13)
- Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett's Esophagus. (2016) (13)
- Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. (2010) (13)
- Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers (2016) (13)
- Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related Hepatocellular Carcinoma (2011) (13)
- Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial (2017) (12)
- A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. (2016) (12)
- Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. (2016) (12)
- Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey (2017) (12)
- Republished: Symptomatic reflux disease: the present, the past and the future (2014) (12)
- Mycobacterium avium complex esophagitis. (1997) (12)
- Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population (2018) (12)
- Physical activity and the risk of Barrett's esophagus. (2016) (11)
- Rational HCC screening approaches for patients with NAFLD (2021) (11)
- Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. (2014) (11)
- Implementation of a Population‐Based Cirrhosis Identification and Management System (2018) (11)
- Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers (2007) (11)
- Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare (2021) (11)
- Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists (2017) (11)
- Habitual Sleep Duration and the Colonic Mucosa-Associated Gut Microbiota in Humans—A Pilot Study (2021) (11)
- Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review (2020) (11)
- A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women (2018) (11)
- Hepatocellular cancer care: cost is important but only one factor of disease burden. (2009) (11)
- Alcohol use alters the colonic mucosa-associated gut microbiota in humans. (2020) (11)
- Current Status of Sorafenib Use for Treatment of Hepatocellular Carcinoma. (2017) (10)
- Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. (2006) (10)
- Preparing for the NASH Epidemic: A Call to Action (2021) (10)
- Esophageal COX-2 Expression Is Increased in Barrett’s Esophagus, Obesity, and Smoking (2014) (10)
- 196 Caffeine Consumption and the Colonic Mucosa-Associated Gut Microbiota (2019) (10)
- Cholangiocarcinoma: the "other" liver cancer on the rise. (2002) (10)
- Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease (2017) (10)
- Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases (2021) (10)
- Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents (2019) (10)
- Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care. (2020) (10)
- Bundling in medicare patients undergoing bidirectional endoscopy: how often does it happen? (2014) (10)
- Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA (2020) (9)
- Expression of androgen receptors in Barrett esophagus. (2012) (9)
- Applying Lean Design Principles to a Gastrointestinal Endoscopy Program for Uninsured Patients Improves Health Care Utilization. (2015) (9)
- Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1 (2019) (9)
- Associations between diVerent forms of gastro-oesophageal reflux disease (1997) (9)
- Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA (2020) (9)
- Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. (2015) (9)
- Temporal trends in survival of patients with esophageal adenocarcinoma in the United States: 1973–1997 (2001) (9)
- How we approach it: treatment options for hepatocellular carcinoma. (2018) (9)
- Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study. (2017) (9)
- Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-based Cohort of Patients With Cirrhosis of Multiple Etiologies. (2020) (9)
- An Epidemiologic View (2002) (8)
- Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma". (2019) (8)
- Hepatocellular carcinoma and hepatitis C in the United States (2002) (8)
- 810 The Functional Dyspepsia Treatment Trial (Fdtt) Key Results (2013) (8)
- Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally‐Derived Anthropometric Measures (2017) (8)
- Spotlight: COVID-19 PPE and Endoscopy (2020) (8)
- Symptomatic re fl ux disease : the present , the past and the future (2014) (8)
- S1078 Gastric Histology in Children Treated with Proton Pump Inhibitors (PPIs) Long-Term (2008) (8)
- CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. (2013) (8)
- Prevalence of Gastric Intestinal Metaplasia in a Multi-Ethnic United States Veterans Population. (2020) (8)
- Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. (2019) (8)
- Scientific manuscripts: the fun of writing and submitting. (2006) (8)
- Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients with Cirrhosis. (2020) (7)
- 120 Circulating Inflammatory Cytokines and Adipokines Are Associated With Barrett's Esophagus: A Case-Control Study (2013) (7)
- Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency. (2020) (7)
- Curbside Consultations: The Good, the Bad, and the Ugly. (2016) (7)
- The dawn of a new era: transforming our domestic response to hepatitis B & C. (2010) (7)
- Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV (2016) (7)
- Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans (2021) (7)
- Acid-suppressive medications and risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: A systematic review and meta-analysis. (2014) (7)
- Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy (2012) (7)
- Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. (2021) (7)
- Persistent Challenges in the Hepatitis C Virus Care Continuum for Patients in a Central Texas Public Health System (2020) (7)
- CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. (2013) (7)
- Hepatocellular Carcinoma in the Absence of Cirrhosis in US Veterans is Associated with Non-Alcoholic Fatty Liver Disease (2015) (7)
- Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma. (2017) (7)
- Decision aids for shared decision-making in Barrett's esophagus surveillance. (2015) (6)
- Occupational Exposure and the Risk of Barrett’s Esophagus: A Case–Control Study (2013) (6)
- Barrett's esophagus: best practices for treatment and post-treatment surveillance. (2017) (6)
- Hepatitis C virus‐related complications are increasing in women veterans: A national cohort study (2017) (6)
- Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence (2013) (6)
- Is Proton Pump Inhibitor Use Associated With Risk of Myocardial Infarction? (2016) (6)
- Risk factors for intra- and extrahepatic cholangiocarcinoma in the United States: a population based case-control study (2007) (6)
- External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population (2020) (6)
- Antiviral Treatment for Hepatitis C Virus is Associated With a Reduced Risk of Hepatocellular Carcinoma in a National Cohort of U.S. Veterans (2011) (5)
- Dietary History and Physical Activity and Risk of Advanced Liver Disease in Veterans with Chronic Hepatitis C Infection (2011) (5)
- Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection (2015) (5)
- Hepatocellular Carcinoma and Smoking: Oblivion or Contempt? (2013) (5)
- Segment length and risk for neoplastic progression in patients with Barrett esophagus. (2000) (5)
- Dietary Fatty Acid Intake and the Colonic Gut Microbiota in Humans (2022) (5)
- Risk Profiles for Barrett’s Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases (2016) (5)
- Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population (2021) (5)
- Improving quality of care in patients with cirrhosis (2013) (5)
- Hepatitis C infection: dying with or from the infection? (2008) (5)
- Incidence and survival of colorectal cancer in the US: 1989–1997 (2001) (5)
- Genetic association studies: from "searching under the lamppost" to "fishing in the pond". (2008) (5)
- Oral Health and the Altered Colonic Mucosa-Associated Gut Microbiota (2020) (5)
- Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans (2020) (4)
- Dietary Fructose Intake and Severity of Liver Disease in Hepatitis C Virus-infected Patients (2013) (4)
- Association Between Facility Characteristics and the Process of Care Delivered to Patients with Hepatitis C Virus Infection (2014) (4)
- Barrett's esophagus: clinical features, obesity, and imaging (2011) (4)
- Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients (2019) (4)
- #68 Is there a true “shift” to the right in the incidence of colorectal cancer? (2002) (4)
- Chapter 10 – Epidemiology and Molecular Mechanisms of Hepatocarcinogenesis (2012) (4)
- Brief report: the length of newly diagnosed Barrett's esophagus may be decreasing. (2015) (4)
- The length of newly diagnosed Barrett’s esophagus and prior use of acid suppressive therapy (2003) (4)
- Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection (2020) (4)
- 4 - Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer (HCC) in Non-Alcoholic Fatty Liver Disease (NAFLD) (2018) (4)
- Associations of Duration, Intensity, and Quantity of Smoking With Risk of Gastric Intestinal Metaplasia (2020) (4)
- Risk of Hepatobiliary and Pancreatic Cancers Following Hepatitis C Virus Infection (2010) (4)
- COMPLICATIONS OF PEDIATRIC COLONOSCOPY (2006) (4)
- Clinical and psychosocial variables associated with behavioral intentions to undergo surveillance endoscopy (2014) (4)
- Endoscopic Manifestations of Erosive Esophagitis in Children (2004) (4)
- Absolute Risk of Hepatocellular Carcinoma in a Large, Geographically and Ethnically Diverse Cohort of Patients with Non-Alcholic Fatty Liver Disease (2017) (3)
- Surveillance for Hepatocellular Carcinoma (2011) (3)
- The Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population. (2021) (3)
- Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures. (2019) (3)
- Risk factors for the rising rates of hepatocellular carcinoma in the united states (2000) (3)
- A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis (2021) (3)
- DURABILITY AND EFFECTIVENESS OF COGNITIVE BEHAVIORAL THERAPY FOR IRRITABLE BOWEL SYNDROME. (2019) (3)
- Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. (2018) (3)
- Personal and family history of cancer and the risk of Barrett's esophagus in men. (2015) (3)
- ORIGINAL ARTICLES—LIVER, PANCREAS, AND BILIARY TRACT Level of -Fetoprotein Predicts Mortality Among Patients With Hepatitis C-Related Hepatocellular Carcinoma (2011) (3)
- Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. (2019) (3)
- Esophageal eosinophilia after radiofrequency ablation for Barrett's esophagus. (2013) (3)
- Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization (2019) (3)
- Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population (2021) (3)
- Chronic corpus gastritis is protective against erosive esophagitis (1998) (3)
- A multidisciplinary approach to improving transition readiness in pediatric liver transplant recipients (2020) (3)
- Real world experience with elbasvir/grazoprevir in the Veterans Affairs Healthcare System (2017) (3)
- Cancer Prevention and Research Institute of Texas - CPRIT (2020) (3)
- How to Prepare for and Write a Grant: Personal Perspectives. (2017) (3)
- The treatment path in hepatocellular carcinoma. (2017) (3)
- Abstract 1816: Attributable risks for hepatocellular carcinoma in the United States (2010) (3)
- Manuscript writing. (2008) (3)
- Current Status of Chemoprevention in Barrett's Esophagus. (2021) (3)
- 636 HCC in the Absence of Cirrhosis in United States Veterans: an Emerging Disease Entity Associated With Features of Metabolic Syndrome (2014) (3)
- Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes (2022) (3)
- Altered Expression of Autophagy-related Genes in Human Colon Cancer (2017) (3)
- Phase 3 biomarker study for HCC surveillance using AFP, AFP L-3 and DCP. A prospective collection with retrospective blinded evaluation (2017) (3)
- M1575: The Frequency and Determinants of Polyps in Children: Results From a National Endoscopic Database (2010) (3)
- COMPLICATIONS OF PEDIATRIC UPPER ENDOSCOPY: 120 (2005) (2)
- Su1249 – Demographic, Lifestyle and Dietary Risk Factors for Gastric Intestinal Metaplasia Among US Veterans (2019) (2)
- 1022 METABOLIC SYNDROME INCREASES THE RISK OF PRIMARY LIVER CANCER IN THE UNITED STATES (2011) (2)
- Advances in the management of hepatocellular carcinoma. (2017) (2)
- A Farewell From the Board of Editors of the Blue Journal. (2017) (2)
- The Top Five Reasons You Should Publish in Clinical Gastroenterology and Hepatology. (2017) (2)
- Sa1061 Nonalcoholic Fatty Liver Disease (NAFLD) in the Veterans Administration Population: Development and Validation of an Algorithm for NAFLD Using Automated Data (2014) (2)
- Neighborhood-level factors contribute to disparities in hepatocellular carcinoma incidence in Texas. (2022) (2)
- Serum Levels of Lipopolysaccharides and Risk of Advanced Colorectal Adenoma (2020) (2)
- Racial Differences in the Association Between Adiposity Measures and the Risk of Hepatitis C-related Liver Disease (2012) (2)
- Corrigendum: Barrett's Esophagus Suspected at Endoscopy but No Specialized Intestinal Metaplasia on Biopsy, What's Next? (2014) (2)
- Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease (2012) (2)
- Colonic mucosal abnormalities associated with bowel preparations (1995) (2)
- Surveillance for hepatocellular carcinoma: does it work? (2002) (2)
- Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. (2022) (2)
- The Renal and Urologic Complications of Inflammatory Bowel Disease (1997) (2)
- Differential Expression of Tight Junctions and Cell Polarity Genes in Human Colon Cancer (2018) (2)
- LIVER Diabetes increases the risk of hepatocellular carcinoma in the United States : a population based case control study (2005) (2)
- Is the prevalence of GERD symptoms lower in blacks? a population-based study (2003) (2)
- 775 Beverage Intake and the Risk of Advanced Fibrosis in HCV: Coffee, Tea, or Sodas? (2014) (2)
- Low Yield of Hepatitis C Infection in an Outreach Screening Program in Harris County, Texas (2020) (2)
- Distribution and manifestations of Inflammatory Bowel Disease in non Caucasians: A systematic review: P-0078. (2008) (2)
- Utilization and outcomes of primary tumor surgery for stage IV colon cancer in the United States: A population-based study. (2012) (2)
- Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis (2018) (2)
- Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC) (2022) (2)
- Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients with and without Antibiotic Exposure: A Retrospective Cohort Study. (2021) (2)
- Preparing for the NASH epidemic: A call to action (2021) (2)
- Abstract 4300: Novel metabolism pathway in pancreatic cancer: findings from targeted metabolomics study (2016) (2)
- EGD IN CHILDREN WITH ABDOMINAL PAIN (2006) (2)
- Associations between di V erent forms of gastro-oesophageal reflux disease (1998) (2)
- Barrett's esophagus, hiatal hernia, and logistic regression analysis (1999) (2)
- Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy (2022) (2)
- Guideline adherence for diagnosis of liver cancer in veterans. (2013) (2)
- Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma. (2018) (2)
- Proton pump inhibitors reduce the incidence of dysplasia in Barrett’s esophagus (2003) (2)
- 835 Insulin Treatment and the Risk of Hepatocellular Carcinoma in Patients with Diabetes (2009) (2)
- Why send your paper to Gastroenterology: global outreach and partnerships with sister journals, CGH and CMGH, among a menu of offerings. (2015) (2)
- Endoscopic ablation of low-grade dysplasia in Barrett's esophagus: Have all the boxes been checked for us to move on? (2017) (2)
- A Conceptual Model for Implementation and Evaluation of Interventions across the Hepatocellular Carcinoma Care Continuum. (2021) (2)
- Barrett's Esophagus in Children and Adolescents Without Neurodevelopmental or Tracheoesophageal Abnormalities (2009) (2)
- Immediate Complications of Upper Endoscopy in Children (2006) (2)
- PS-182-Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection who receive opioid agonist therapy: Treatment utilization and the impact of concomitant psychiatric medications (2019) (2)
- T1014 Hepatitis C Infection (HCV) and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis (2008) (2)
- Dairy Intake and Mucosa-Associated Gut Microbiome in Healthy Individuals: Presidential Poster Award (2018) (2)
- THU-170-Real-world effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 4 infection: Results from a Veterans Affairs population (2019) (1)
- Inverse association between gluteofemoral obesity and risk of non-cardia gastric intestinal metaplasia. (2022) (1)
- The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes. (2020) (1)
- Risk factors for hepatocellular carcinoma: A case control study among US veterans (2001) (1)
- Ethnic variations in the prevalence of esophageal endoscopic findings: A population-based study (2003) (1)
- Tu1489 - Improved Treatment Delivery and Overall Survival Associated with Multidisciplinary Tumor Board Evaluation of Patients with Advanced Hepatocellular Carcinoma (2018) (1)
- Serum Levels of Zonulin and Risk of Colorectal Tumor: A Pilot Case Control Study (2018) (1)
- Su1815 Natural Language Processing Accurately Identifies Colorectal Dysplasia in a National Cohort of Veterans with Inflammatory Bowel Disease (2016) (1)
- 4 Using hierarchial linear modeling to examine geographic variation in hepatocellular carcinoma (2002) (1)
- Tu1030 The Adjusted AFP Algorithm Improves the Predictive Value for HCC During Surveillance (2013) (1)
- Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. (2023) (1)
- Sa1878 Metabolic Syndrome and the Risk of Barrett's Esophagus in White Males (2015) (1)
- Development and Validation of the Houston-BEST, a Barrett's Esophagus Risk Prediction Model Adaptable to Electronic Health Records. (2022) (1)
- Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention (2023) (1)
- The Art and Science of Managing Liver Disease. (2015) (1)
- 12 The Risk Factors of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Chronic Hepatitis B Patients in United States Veterans (2016) (1)
- Tu1315 Clinical and Psychosocial Variables Associated With Behavioral Intentions to Undergo Surveillance Endoscopy (2014) (1)
- Mo1005 The Epidemiology of Gastroesophageal Reflux Disease: an Updated Systematic Review (2012) (1)
- Obesity and Gastroesophageal Reflux Disease (1)
- Tu1005 Outcomes Associated With Co-Utilization of VA and Medicare Healthcare Benefits in Patients With Hepatocellular Carcinoma (2014) (1)
- Screening and Early Detection (2020) (1)
- Carbamazepine-associated severe bile duct injury (1999) (1)
- Statin use after diagnosis of hepatocellular carcinoma and patient survival: findings from a retrospective cohort study (2019) (1)
- Overview of the viral hepatitis problem. (2010) (1)
- Are histological ailments of the gastric cardia markers of reflux symptoms, H. pylori, or neither? (2003) (1)
- Mo1035 Surveillance and Outcomes in Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma in Veteran Affairs (VA) Population (2014) (1)
- The Risk of Hepatocellular Carcinoma in Entecavir versus Tenofovir Treated U.S. Cohort with Chronic Hepatitis B Virus. (2022) (1)
- 704 Impact of Active Hepatitis B Virus DNA Replication on Clinical Outcomes in Patients With Hepatitis C and B Co-Infection (2014) (1)
- Abstract 1190: Incidence of gastric cancer in the United States during 1999 to 2013: A 50-state analysis (2018) (1)
- Tenofovir vs. entecavir in reducing hepatocellular carcinoma risk in patients with chronic HBV infection?-Still an unsolved question. (2020) (1)
- 788 Bundling in Medicare Patients Undergoing Both Colonoscopy and EGD. How Often Does It Happen (2011) (1)
- The Dawn of a New Era: Transforming Our Domestic Response to Hepatiti sB&C (2010) (1)
- Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease (2022) (1)
- M1855 Gastroesophageal Reflux and Asthma in Children:a Systematic Review (2009) (1)
- Endoscopic Ultrasound in Pancreatic Cancer: Limited Utilization But Improved Outcomes (2006) (1)
- Interferon for postresection recurrence of hepatocellular carcinoma (2002) (1)
- Contemporary changes in etiology for hepatocellular carcinoma in liver transplantation. (2022) (1)
- Tu1429 Is Proton Pump Inhibitor Use Associated With Delayed Gastric Emptying in Functional Dyspepsia Subjects (2015) (1)
- Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study. (2017) (1)
- The Association of Barrettʼs Esophagus and Body Mass Index: 5 (2005) (1)
- Are Patterns and Prevalence Changing (2011) (1)
- Reimbursement for Physicians Performing Endoscopic Submucosal Dissection in The United States: A Single Center Experience: 841 (2017) (1)
- Outcomes of Provider Adherence to NSAID Prescription Guidelines: 1048 (2006) (1)
- NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity? (2022) (1)
- Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population (2021) (1)
- External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of United States veterans. (2022) (1)
- Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease (2022) (1)
- Risk Factors for Hepatocellular Carcinoma: A Historical Perspective (2021) (1)
- EGD in Children with Chronic Abdominal Pain (2009) (1)
- 286 PPI Use and the Risk of Esophageal Cancer in Patients with B.E.: A Nested Case-Control Study (2008) (1)
- Mo1029 Timing and Diagnostic Yield of Endoscopy Among Patients With GERD (2012) (1)
- Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma: How Common? (2015) (1)
- Su1816 Presence of Colonic Dysplasia prior to Colorectal Cancer Diagnosis is Associated with Early Stage Cancer among Patients with Inflammatory Bowel Disease: A National Cohort Study (2016) (1)
- The length of newly diagnosed Barrett's esophagus and prior use of acid suppressive therapy (2003) (1)
- Recent Trends in the Incidence of Gastric Cancer in the United States. (2022) (1)
- Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis (2020) (1)
- Abstract 4591: Differential expression of tight junction polarity genes in human colon cancer (2015) (1)
- Su1842 The Incidence and Prevalence of Anxiety, Depression, and PTSD Among a National Cohort of U.S. Veterans With Inflammatory Bowel Disease (2016) (1)
- Lower Rates of Healing of Erosive Esophagitis (EE) in Nonwhite GERD Patients: 63 (2008) (1)
- Sa1834 Physical Activity and the Risk of Barrett's Esophagus (2014) (1)
- Why Do Small Intraductal Papillary Mucinous Neoplasms Create Such a Huge Management Challenge? (2022) (1)
- Mo1494 Natural History of Untreated HCC in a U.S. Cohort and the Role of Cancer Surveillance (2016) (1)
- W1087 Partial- and Non-Response of Reflux Symptoms to Proton Pump Inhibitors: A Systematic Review of Primary Care and Community-Based Studies (2010) (1)
- Prevention of Hepatocellular Carcinoma (2004) (1)
- 1007 Determinants and Effect of Lag Time Before Colorectal Cancer Diagnosis (2008) (1)
- Colonic Mucosa-associated Mycobiota in Individuals With Normal Colons (2021) (1)
- Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett’s Esophagus in Adults (2016) (1)
- Interferon: benefit beyond hepatitis therapy? (2001) (1)
- Tu1117 - using Natural Language Processing to Accurately Identify Dysplasia in Pathology Reports for Patients with Barrett's Esophagus (2018) (1)
- Epidemiology of esophageal carcinoma (2015) (1)
- Sa1523 COMPARATIVE EFFECTIVENESS OF TENOFOVIR VS. ENTECAVIR IN REDUCING THE RISK OF HEPATOCELLULAR CARCINOMA IN A US COHORT OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION (2020) (1)
- The prevalence and determinants of NAFLD and MAFLD and their severity in the VA primary care setting. (2022) (1)
- Functional Bowel Disease (2015) (1)
- 1118 The effect of HIV co-infection on the risk of cirrhosis and hepatocellular carcinoma in HCV-infected patients (2003) (1)
- Barrett’s esophagus, hiatal hernia, and logistic regression analysis (1999) (1)
- 709 HCV Treatment and SVR: Gaps in the Face of Achieving Effectiveness in Practice (2010) (1)
- Prevalence and Short-term Mortality of Acuteon-Chronic Liver Failure (ACLF) in the Veterans Affairs Hospitals (2004-2014): a National US Cohort. (2017) (1)
- Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population (2022) (1)
- Mo1721 – Increasing Incidence of Advanced Non-Cardia Gastric Cancers Among Younger Hispanics in the United States (2019) (1)
- THU-171-Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection receiving dialysis (2019) (1)
- 285 The Extent and Duration of Using Acid Reducing Medications in Patients with Barrett's Esophagus (2008) (1)
- Chemoprevention of Barrett’s oesophagus: a step closer with PPIs and aspirin (2018) (1)
- Performance of AFP-Based Hepatocellular Carcinoma Surveillance in Cirrhosis Patients with Cured HCV (2017) (1)
- Mo1118 Non-Steroidal Anti-Inflammatory Drugs and the Risk of Barrett's Esophagus (2014) (1)
- Emerging epidemiologic observations in HCV/HIV coinfection (2006) (1)
- 62 Measuring Quality of Care in Patients with Cirrhosis: Development of An Explicit Quality Indicator Set (2009) (1)
- Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply (2020) (1)
- Sa307 NATURAL LANGUAGE PROCESSING IMPROVES THE IDENTIFICATION OF IPMN CYSTS AMONG PATIENTS WITH PANCREATIC CYST DIAGNOSTIC CODES (2021) (0)
- Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma (2019) (0)
- Su1013 Patients’ and Gastroenterologists’ Perspectives on Adherence to Surveillance Endoscopy for Barrett's Esophagus (2012) (0)
- Tu1555 – Risky Alcohol Consumption is Common Among Persons with Viral Hepatitis in the United States: A Population-Based Study (2019) (0)
- Tu1110 - Prevalence of Barrett's Esophagus in Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis (2018) (0)
- Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals (2022) (0)
- Mo1008 Autoimmune Hepatitis and the Incidence of Hepatocellular Carcinoma: A Systematic Review (2015) (0)
- Our New President-John M. Inadomi, MD, AGAF. (2021) (0)
- Effect of Antidepressants on Sleep in Functional Dyspepsia: 1744 (2015) (0)
- High Total Serum Testosterone is Associated With Increased Risk of Advanced Hepatic Fibrosis and Inflammatory Activity in Male Veterans With Chronic Hepatitis C (2011) (0)
- Utilizing a Multidisciplinary Tumor Board for the Management of Hepatocellular Carcinoma is Associated with Improved Outcomes (2017) (0)
- 530: RISK STRATIFICATION MODEL FOR HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS (2022) (0)
- Su1627 PREDICTION OF 1- AND 3-YEAR MORTALITY IN PATIENTS WITH CIRRHOSIS: USE OF MACHINE LEARNING VS. OTHER APPROACHES (2020) (0)
- Effectiveness and utilization of Grazoprevir and Elbasvir in HCV genotype 1 and 4 infection in the veterans affairs healthcare system in the US (2018) (0)
- National Practice Patterns in Tuberculosis and Hepatitis Screening Prior to Tumor Necrosis Factor Antagonist Therapy in Veterans with Inflammatory Bowel Disease: 1789 (2013) (0)
- Tu1845 COMPARATIVE EFFECTIVENESS OF SURVEILLANCE COLONOSCOPY TIMING ON COLORECTAL CANCER OUTCOMES (STAGE, TREATMENT, MORTALITY) IN A NATIONAL COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2020) (0)
- Prevention of hepatocellular carcinoma. Author's reply (2004) (0)
- 336 EFFECT OF ANTI-DIABETES MEDICATIONS ON THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (2020) (0)
- 1017 The Functional Dyspepsia Treatment Trial (FDTT): 5-HTT LPR and Gn β3 825C>T Are Not Pharmacogenetic Markers for FD Antidepressant Treatment Response (2014) (0)
- Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score (2023) (0)
- Proton pump inhibitors reduce the incidence of dysplasia in Barrett's esophagus (2003) (0)
- Reply. (2018) (0)
- 199 Gastric Physiology Test Correlations in Functional Dyspepsia (2015) (0)
- Tu1430 Functional Dyspepsia Treatment Trial (FDTT): Effect of Antidepressants on Mood Response in Functional Dyspepsia (2015) (0)
- 955 – Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 1 Inffection Who Receive Opioid Agonist Therapy: Treatment Utilization and the Impact of Concomitant Psychiatric Medications (2019) (0)
- Mo1446 – An In-Depth Analysis of Hepatocellular Carcinoma Rates in Texas (2019) (0)
- Su1480 Sleep Duration and Incident Liver Cancer in Postmenopausal Women (2016) (0)
- Prevalence and Histological Features of the Gastric Cardia-type Mucosa in Children (2008) (0)
- P1043 THE PREVALENCE OF EROSIVE ESOPHAGITIS IN CHILDREN: A POPULATION-BASED STUDY (2004) (0)
- PHYSICIAN REIMBURSEMENT FOR ESD, A SINGLE CENTER ANALYSIS (2021) (0)
- Mo1000 Association of High Risk Waist-to-HIP Ratio With Barrett's Esophagus, and Their Interaction With Race/Ethnicity (2012) (0)
- T1016 Burden of Cirrhosis in a National Sample of Patients with Chronic Hepatitis C (2008) (0)
- Sa355 POSTMENOPAUSAL WOMEN HAVE THE HIGHEST RISK OF ADVANCED NAFLD FIBROSIS (2021) (0)
- T1005 Quality of Care in Spontaneous Bacterial Peritonitis (2010) (0)
- IRON DEFICIENCY ANEMIA AND HIATAL HERNIA (2001) (0)
- 416 IMPROVING ADHERENCE TO GASTRIC INTESTINAL METAPLASIA CLINICAL PRACTICE GUIDELINES AMONG GASTROENTEROLOGISTS AT A U.S. ACADEMIC INSTITUTION (0)
- What Is the Role of Gene – Disease / Phenotype Association Studies in Finding Genetic Causes of Disease ? (0)
- Obesity and Barrettʼs Esophagus in Hispanics: 2 (2010) (0)
- Sa1821 The Association of Obesity and Barrett's Esophagus, A Meta-Analysis (2014) (0)
- P0858 THE PREVALENCE OF EROSIVE ESOPHAGITIS IN CHILDREN: A POPULATION-BASED STUDY (2004) (0)
- Proton Pump Inhibitor and Nonsteroidal Anti-Inflammatory Use and the Development of Neoplasia in Barrettʼs Esophagus: 11 (2007) (0)
- Sa1132: VALIDATION OF PRE-ENDOSCOPY RISK SCORE FOR PREDICTING THE PRESENCE OF GASTRIC INTESTINAL METAPLASIA IN A U.S POPULATION (2022) (0)
- Weight Change and Weight Cycling Are Not Associated With Risk of Barrett's Esophagus. (2016) (0)
- Reply: To PMID 24957400. (2015) (0)
- 300 The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus (2016) (0)
- Tu1116 - Prior Diagnosis of Barrett's Esophagus in Patients with Esophageal Adenocarcinoma is Infrequent, but Associated with Improved Survival (2018) (0)
- 637 Temporal Trends of Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma in Veteran Affairs (VA) Population (2014) (0)
- Su1008 Extent and Determinants of Endoscopic Surveillance in 29,045 Patients With Barrett's Esophagus (2012) (0)
- Su1013 BURDEN OF PANCREATIC CANCER: FOUR DECADES OF U.S. EXPERIENCE (2020) (0)
- Abstract LB-382: A prospective study of soluble receptor for advanced glycation end products and adiponectin and pancreatic cancer in postmenopausal women (2016) (0)
- Tu1033 Treatment and Outcomes of Hepatocellular Carcinoma in Patients With Idiopathic Disease (2013) (0)
- CLINICAL—ALIMENTARY TRACT Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus (2010) (0)
- Issue Highlights. (2016) (0)
- Reply. (2019) (0)
- Gastrointestinal stromal tumors (GIST) in the U.S.: 1975–1999; the gist of it (2003) (0)
- Tu1500 - Risk of Hepatocellular Cancer Recurrence in HCV Patients Treated with Direct-Acting Antiviral Agents in a United States Veteran Population (2018) (0)
- Abstract LB-160: Genetic variations in the AGEs/AGER pathway and risk of pancreatic cancer (2017) (0)
- Abstract 48: Instrumental variable analysis on soluble receptor for advanced glycation end products and risk of pancreatic cancer: A pilot study. (2012) (0)
- Post operative 30-day mortality following surgical resection of colorectal cancer in veterans: Temporal changes in the right direction (2003) (0)
- HCC Surveillance in NAFLD patients. (2022) (0)
- Prevalence of Celiac Disease Among Unsuspected Patients Presenting to Open Access Endoscopy (2017) (0)
- edication Usage and the Risk of Neoplasia in Patients ith Barrett ’ s Esophagus (0)
- Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans (2021) (0)
- Incidence of Hepatocellular Carcinoma in Primary Biliary Cirrhosis: A Systematic Review: 2199 (2015) (0)
- Tu1011 Quality of Varices-Related Care in Patients With Cirrhosis (2012) (0)
- Tu1435 Functional Dyspepsia Treatment Trial (FDTT): Association of Adequate Relief Response and Psychological Measures (2015) (0)
- Prospective implementation of algorithmic patient selection for gastrostomy tube placement consultations: a pre- and post-intervention analysis (2019) (0)
- Psychiatric comorbidity in veterans referred for hepatitis C treatment (2003) (0)
- Su1079 Changes in the Incidence and Prevalence of Cirrhosis in the National Veterans Administration Over a Decade: 2002-2012 (2015) (0)
- T1004 Over-Utilization of Hepatitis C Antibody Testing and Its Impact on the Quality of Care in Patients With Chronic Hepatitis C Virus Infection (2010) (0)
- Sa1832 The Length of Newly Diagnosed Barrett's Esophagus Has Been Decreasing Over Time (2014) (0)
- Tu1004 Nonalcoholic Fatty Liver Disease Is Underrecognized in the Primary Care Setting (2014) (0)
- Mo1160: EXTERNAL VALIDATION OF A PREDICTIVE MODEL DETERMINING RISK OF NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS IN A COHORT OF UNITED STATES VETERANS (2022) (0)
- GERD is a Risk Factor for Sleep Disturbance Independent of Sleep Apnea (2011) (0)
- Association Between Race and the Perception and Resolution of heartburn (Hb) in Patients with GERD: 1020 (2008) (0)
- Mo1116 Statin Use May Decrease the Risk of Barrett's Esophagus: A Case-Control Study of U.S. Veterans (2014) (0)
- Tu1881 - Association Between Body Mass Index and Composition of Mucosa Associated Intestinal Microbiota in Healthy Individuals (2018) (0)
- Prospective Implementation of Algorithmic Patient Selection for Gastrostomy Tube Placement Consultations: A Pre-, Post-Analysis (2017) (0)
- Clinical Determinants of Alpha Fetoprotein Values in a Set of 258,275 Tests Conducted in Patients With HCV Infection (2011) (0)
- The Science and Art of Managing Liver Disease: An Introduction (2015) (0)
- Occupational History and the Risk of Barrettʼs Esophagus: 40 (2012) (0)
- Natural progression of childhood onset inflammatory bowel disease - A systematic review. (2011) (0)
- Low Insurance Coverage Among Hepatitis C (HCV)-Positive Individuals in the United States (2011) (0)
- Mo1171 Disordered Eating Behaviors in Functional Dyspepsia Patients (2012) (0)
- 404 RISK OF POST-COLONOSCOPY IRRITABLE BOWEL SYNDROME IN PATIENTS WITH AND WITHOUT ANTIBIOTIC EXPOSURE (2020) (0)
- S1608 The Risk of Gastric Cancer (Overall and Cardia Only) With the Use of Proton Pump Inhibitors in Observational Studies: A Systematic Review and Meta-Analysis (2022) (0)
- AJG-21-1081 280..287 (0)
- P785 PROJECTED HEALTH AND ECONOMIC IMPACT OF HEPATITIS C ON THE UNITED STATES VETERANS ADMINISTRATION HEALTH SYSTEM FROM 2014 TO 2024 (2014) (0)
- 140 Acid Suppression Therapy Reduces Risk of Progression From Barrett's Esophagus to Esophageal Adenocarcinoma: A Nested Case-Control Study in US Veterans (2016) (0)
- Improving Adherence to Gastric Intestinal Metaplasia Clinical Practice Guidelines Among Gastroenterologists at a U.S. Academic Institution (2021) (0)
- Intrahepatic cholangiocarcinoma in the United States: A true increase or increased detection? (2003) (0)
- 692: DEVELOPMENT AND VALIDATION OF AN AUTOMATED PREDICTION MODEL DETERMINING BARRETT'S ESOPHAGUS RISK WITH TERMS FROM THE ELECTRONIC MEDICAL RECORD (2022) (0)
- Improved survival following esophageal variceal hemorrhage in the department of veterans affairs (VA) (2000) (0)
- 612 Effect of Hepatitis C Viral Factors and Overall Immune Suppression on the Risk of Hepatocellular Carcinoma in Patients With HCV-HIV Coinfection (2013) (0)
- 505 COMPARATIVE PERFORMANCE OF PREDICTION MODELS OF HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA IN THE UNITED STATES POPULATION (2021) (0)
- Mo1401 - Impact of Acid-Reducing Agents on Effectiveness of Elbasvir/Grazoprevir in a us Veterans Affairs Population with Hepatitis C Virus Infection (2018) (0)
- M1001 Quality of Diagnosis and Evaluation-Related Care in Patients with Chronic Hepatitis C Virus Infection (2009) (0)
- Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease. (2022) (0)
- Effectiveness of Hepatitis C Virus (HCV) Antiviral Treatment in Veterans With HIV-HCV Coinfection (2011) (0)
- Opportunities to Address Gaps in Early Detection and Improve Outcomes of Liver Cancer. (2023) (0)
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men (2019) (0)
- Tu1010 Automated Data Underestimate Quality of Care in HCV (2012) (0)
- Correction to: A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study (2022) (0)
- Immediate Complications of Pediatric Colonoscopy (2007) (0)
- Tu1457 Diagnostic Utility of Fecal Elastase-1 in Exocrine Pancreatic Insufficiency - A Systematic Review and Meta-Analysis (2016) (0)
- T1000 Utilization of Surveillance for Hepatocellular Carcinoma Among HCV Infected Patients in the United States (2010) (0)
- The Effect of surgical volume on long term survival for colorectal cancer (2003) (0)
- Mo1271 Age Moderates the Relationship Between Medical Comorbidities and Distress in IBS Patients (2015) (0)
- Response to letter to the editor from Zhou et al (Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease). (2022) (0)
- Behavioral Medicine Services for Patients With Irritable Bowel Syndrome: Development of a Referral Toolkit for Gastroenterology Providers: 467 (2017) (0)
- Sa1092 Higher Total Serum Testosterone Level is Associated With Increased Risk of Biopsy-Confirmed Advanced Hepatic Fibrosis and Inflammation but Not Advanced Steatosis in Male Veterans With Chronic Hepatitis C (2012) (0)
- Large Databases for Epidemiologic Studies (2008) (0)
- Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients with Barrett's Esophagus. (2022) (0)
- Impact of acid-reducing agents on effectiveness of Elbasvir/Grazoprevir in treating US veterans affairs population with hepatitis C virus (2018) (0)
- One Year Risk Trajectories of Mortality and Readmission in Patients with Cirrhosis-Related Hospitalizations (2017) (0)
- T1015 Rate and Predictors of Erythropoietic Growth Factors Use in Chronic Hepatitis C Patients with Treatment Induced Anemia (2008) (0)
- In Functional Dyspepsia, Are Postprandial Distress Syndrome and Epigastric Pain Syndrome Different? (2011) (0)
- Validation of ICD-9 Codes Used for the Diagnosis of Upper Gastrointestinal Events (UGIE) Following NSAID Prescription (2005) (0)
- 384: EFFECT OF THE INTERPLAY BETWEEN PNPLA3 I148M VARIANT, ALCOHOL INTAKE, AND OBESITY ON THE RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2022) (0)
- Gastroesophageal Reflux and the Obesity Epidemic. (2006) (0)
- Colorectal Cancer in Hispanics: A Population-Based Study of Trends in Incidence and Survival (2011) (0)
- 1005 Patient Race and Risk of Cirrhosis and Hepatocellular Cancer in a National Sample of Veterans With HCV (2014) (0)
- Incidence and prevalence of extrahepatic manifestations of HCV (2018) (0)
- S409 The Prevalence of Dysplasia in Ultrashort Barrett's Esophagus in a United States Veteran Population (2022) (0)
- Epidemiological differences between gastric cardia adenocarcinoma and esophageal adenocarcinoma (2000) (0)
- Su374 THE PREVALENCE AND SEVERITY OF METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN THE VA PRIMARY CARE SETTING (2021) (0)
- Su1167 Human Papilloma Virus (HPV) and the Risk of Barrett's Esophagus (2012) (0)
- Tu1219 - Screening and Surveillance for Barrett's Esophagus in Veterans Subsequently Diagnosed with Esophageal Adenocarcinoma (2018) (0)
- Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019 (2022) (0)
- Bioelectric Impedance Measurements as Predictors of HCV-Related Hepatic Fibrosis and Inflammation (2011) (0)
- Abstract 4946: The association between antihypertensive medication, sRAGE, and risk of pancreatic cancer: Results from the Women's Health Initiative Study (2018) (0)
- Tu1053 HCV-Related Complications Are Increasing in Women Veterans: A National Cohort Study (2015) (0)
- The effect of gaps in chemotherapy in patients with stage IV colorectal cancer. (2013) (0)
- Response to Braillon. (2013) (0)
- The Temporal Trends in Incidence of Intra and Extrahepatic Cholangiocarcinoma in the United States and the Impact of Klatskin Tumor Classification (2011) (0)
- Sa1870 Cirrhosis Is Underrecognized in Patients Subsequently Diagnosed With HCC (2015) (0)
- At Last—A Treatment for IBS Beyond Placebo (2003) (0)
- The Association between Caffeine Intake and the Colonic Mucosa-Associated Gut Microbiota in Humans—A Preliminary Investigation (2023) (0)
- The clinical course of GERD from childhood to adulthood (2003) (0)
- Sa1879 Obesity, Adipokines, Inflammatory Markers and Risk of Neoplastic Progression in BE: A Cohort Study (2015) (0)
- Specialty Evaluation in Patients With Chronic Hepatitis C Virus Infection—Role of Patient Versus Non-Patient Factors (2011) (0)
- S1328 Examining Associations Between Arsenic Pollution and Hepatocellular Carcinoma in Texas (2022) (0)
- NATIONAL ADHERENCE TO ACG GUIDELINES FOR THE SAFE PRESCRIPTION OF NSAID: 712 (2004) (0)
- Changing Temporal Trends of Gastroparesis-Related Emergency Department Visits and Inpatient Hospitalizations in a National U.S. Cohort: 1239 (2017) (0)
- Assessment of Disease-specific Knowledge among Veterans with Inflammatory Bowel Disease: 1788 (2013) (0)
- 474 Activated Duodenal Eosinophils Are Associated With Early Satiety-Predominant Functional Dyspepsia: Results From a U.S. Veteran Cohort (2019) (0)
- Linking Quality of Hepatitis C Virus Care to Treatment and Virologic Response (2011) (0)
- Psychological Treatments for Irritable Bowel Syndrome Conducted in Gastroenterology Settings: A Systematic Review (2017) (0)
- Su1266 Psychosocial Traits, Clinical Symptoms, and Community Factors Are All Associated With Tertiary Care Referral/Management in Pediatric Functional Abdominal Pain (FAP) and Irritable Bowel Syndrome (IBS) (2014) (0)
- IBD in Hispanics and Caucasians: Disease characteristics and treatment: P-0054. (2009) (0)
- Tu1061 Angiotensin Converting Enzyme Inhibitors (Acei) Are Not Associated With Severity of Fibrosis in Patients With Hepatitis C Virus (HCV) (2015) (0)
- Su1486 Ongoing Increases in HCC Incidence Disproportionately Impact Specific Sub-Groups and Geographic Regions (2016) (0)
- Sa2041 Hematologic Monitoring After Immunomodulator Initiation in Veterans With Inflammatory Bowel Disease: A Practice Audit (2012) (0)
- Tu1920 ASSOCIATION BETWEEN DIETARY FAT INTAKE AND THE COLONIC GUT MICROBIOTA IN HUMANS (2020) (0)
- The Prevalence of Erosive Esophagitis in Children: A Population-based Study (2004) (0)
- S1507: Prevalence of Eosinophilic Esophagitis in Unselected Patients Presenting to Endoscopy: A Large Prospective Study (2010) (0)
- Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285]. (2019) (0)
- Mo1900 Barrett's Esophagus At Endoscopy but No Intestinal Metaplasia on Biopsy, What's Next? (2013) (0)
- Chapter Forty-Five – Primary tumors of the liver (2006) (0)
- Diet and risk of development of inflammatory bowel diseaseA systematic review.: P-118. (2011) (0)
- Sa1387: SUPPLEMENTAL TESTOSTERONE THERAPY USAGE AMONG MALE VETERANS WITH HCV-RELATED LIVER DISEASE USING VA HEALTHCARE ASSOCIATED WITH REDUCED RELATIVE RISK OF DEVELOPING INCIDENT HEPATCELLULAR CARCINOMA (2022) (0)
- The dawn of a new era: Transforming our domestic response to hepatitis B & C: Activity 1: Overview of the viral hepatitis problem (2010) (0)
- Admixture mapping in African Americans identifies new risk loci for HCV-related cirrhosis. (2022) (0)
- T1020 HCV Antiviral Treatment Among US Veterans with Chronic Hepatitis C Infection: Patient, Provider, and Facility Predictors (2008) (0)
- EFFECT OF PANTOPRAZOLE ON THE COURSE OF REFLUX-ASSOCIATED LARYNGITIS: A PLACEBO-CONTROLLED, DOUBLE-BLIND CROSSOVER STUDY (2003) (0)
- Rates, Risk and Predictors of Barrett's Esophagus Recurrence After Radiofrequency Ablation in a Community Practice Setting: A National Veterans Cohort Study (2017) (0)
- M1000 Completion of Hepatitis C Virus (HCV) Treatment in Community Based Practice—An Insight Into the Effectiveness of Treatment (2009) (0)
- Mo1445 – The Performance of Triple Biomarkers (AFP, AFP-3, DCP) for Early Detection of Hepatocellular Carcinoma (HCC). A Prospective Cohort Phase 3 Biomarker Study in the United States (2019) (0)
- Hepatocellular carcinoma in Houston, Texas: rising incidence over the last ten years (2003) (0)
- M1075 Measuring and Improving the Timeliness of Colorectal Cancer Diagnosis: A Mixed-Methods Approach (2010) (0)
- Sa1958 Statin Use May Decrease the Risk of Esophageal Adenocarcinoma (EA): A Nested Case-Control Study of US Veterans (2015) (0)
- Limits of the AGA Practice Update for Barrett's Esophagus Screening: A Proposal for Electronic Health Record-Adaptable Risk Models. (2022) (0)
- 1208 Contemporary Prevalence and Predictors of Helicobacter pylori Infection in a U.S. Population (2019) (0)
- Temporal Trends in Pre-Diagnosis Screening and Surveillance Among Patients with Newly Diagnosed CRC. A Healthcare System Quality Measure? (2017) (0)
- Editorial Hepatitis C infection: Dying with or from the infection? q (2008) (0)
- Su1084 The Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-Analysis (2015) (0)
- 466 Statins Are Underutilized in Patients With Nonalcoholic Fatty Liver Disease and Dyslipidemia (2015) (0)
- P1046 ENDOSCOPIC MANIFESTATIONS OF EROSIVE ESOPHAGITIS IN CHILDREN (2004) (0)
- Presentation of the AGA William Beaumont Prize in Gastroenterology to David Y. Graham, MD. (2021) (0)
- Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett’s esophagus (2013) (0)
- P152 PATIENT EXPERIENCES WITH COLORECTAL CANCER SURVEILLANCE (CRC) IN INFLAMMATORY BOWEL DISEASE (IBD): A QUALITATIVE STUDY (2018) (0)
- 284 Tuberculosis and Hepatitis B Reactivation Are Rare After Treatment With Tumor Necrosis Factor Antagonist Therapy Among Patients With Inflammatory Bowel Disease (2015) (0)
- 811 – Risk of Hepatic Disease Progression in Patients with Nonalcoholic Fatty Liver (NAFLD)-Related Cirrhosis (2019) (0)
- 419 Type and Timing of Trauma History and Risk of Irritable Bowel Syndrome in Women Veterans (2009) (0)
- Authors' response to Letter to the Editor from Liu and Li regarding Risk for post-colonoscopy irritable bowel syndrome in patients with and without antibiotic exposure. (2021) (0)
- Anniversary Tribute From the Editors of Clinical Gastroenterology and Hepatology. (2017) (0)
- Sa2032 – Alcohol Consumption and the Colonic Mucosa-Associated Gut Microbiota in Individuals Undergoing Screening Colonoscopy (2019) (0)
- The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population. (2022) (0)
- How to Find and Apply Large Databases for Epidemiologic Research (2014) (0)
- Epidemiology of Gastric Intestinal Metaplasia and Gastric Cancer (2023) (0)
- Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference. (2023) (0)
- Mediating effects of neighborhood-level socioeconomic deprivation on the association between race/ethnicity and advanced hepatocellular carcinoma. (2022) (0)
- SHOULD WE EXPAND THE SCREENING RECOMMENDATIONS FOR HEPATITIS C TO INCLUDE EXTRAHEPATIC DISORDERS (2003) (0)
- Reply to Letter to the Editor regarding the Houston Consensus conference on testing for H. pylori infection in the United States (2019) (0)
- Response to Jolobe (2010) (0)
- Correlation of Colonic Thickening on Computed Tomography (CT) with Colonoscopy (2004) (0)
- Mo1891 QUALITY OF TRANSITION CARE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (2020) (0)
- Eosinophilic Esophagitis after Radiofrequency Ablation for Barrettʼs Esophagus: Causal or Coincidence?: 7 (2011) (0)
- 293 - Effectiveness and Utilization of Elbasvir/Grazoprevir in HCV Genotype 1 and 4 Infection in the Veteran Affairs Healthcare System in the United States (2018) (0)
- The Prevalence of Helicobacter pylori-Negative Gastritis (2011) (0)
- Determinants of intestinal metaplasia in the antrum, corpus, and cardia of the stomach (2000) (0)
- Abstract 4638: Plasma levels of soluble receptor for advanced glycation end-products and risk of colorectal polyps in men (2011) (0)
- Gender Differences in Psychologic Parameters in Functional Dyspepsia: 1320 (2011) (0)
- Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection. (2019) (0)
- Alpha-Fetoprotein Levels Are Predictive of Survival in Hepatitis C-Related Hepatocellular Carcinoma in a United States Veterans Cohort (2011) (0)
- Screening is Associated with Survival Benefit in the in an Silico but Needs Confirmation in an Vivo Analysis (2018) (0)
- Determinants and Outcomes of Curative Intent Surgery for Pancreatic Cancer in the United States: 752 (2005) (0)
- Sa1670 - Expression of Pattern Recognition Receptor Pathway Genes and Colorectal Neoplasms (2018) (0)
- Tu1845 In Functional Dyspepsia, Are Meal-Related Symptoms Linked to Less Drinking Capacity? (2014) (0)
- P0681 the Determinants of the Delay in Diagnosing Inflammatory Bowel Disease in Children (2004) (0)
- Statins Use and Overall Survival in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis (2017) (0)
- Mo1275 A New Lab Based Algorithm for HCC Surveillance in Patients With Cirrhosis (2014) (0)
- S0510 Development of a Referral Toolkit for IBS-Focused Behavioral Medicine Services: A Qualitative Study (2020) (0)
- Statin Use and the Risk of Colorectal Cancer in Patients with Diabetes: 881 (2007) (0)
- Risk of Upper Gastrointestinal Cancers in Patients with Gastroesophageal Reflux Disease Following a Negative Screening Endoscopy (2015) (0)
- Utilizing Natural Language Processing (NLP) to Accurately Identify Fatty Liver Disease (2017) (0)
- Differences in Health Care Visits Coded for Potential Proxy Conditions/Symptoms of Gastroesophageal Reflux Disease (GERD) before and after a GERD Diagnosis: A Pediatric Database Study: 905 (2007) (0)
- The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy (2022) (0)
- Recent decline in the incidence of hepatocellular carcinoma in the United States. (2022) (0)
- Survival among patients with hepatocellular carcinoma in the United States: (1977 to 1996) (2000) (0)
- Sa1191 PREVALENCE AND PREDICTORS OF BARRETT'S ESOPHAGUS IN A NONREFERRED PRIMARY CARE POPULATION (2020) (0)
- Su1484 - Genetic Ancestry and Risk of Hepatic Inflammation and Fibrosis in Patients with Chronic HCV (2018) (0)
- Role of Extrahepatic Comorbidity and Functional Limitations in Predicting Mortality in Patients With HCV: 2358 (2015) (0)
- HuGE Reviews and Meta-analysis of Gene Association Studies (2007) (0)
- Why Are the Recommendations of the CDC and USPSTF Conflicting ? (0)
- Sa1920 – Oral Health and the Colonic Mucosa-Associated Gut Microbiota in Individuals Undergoing Screening Colonoscopy (2019) (0)
- Su1955 - One-Carbon Metabolism Nutrients in Relation to Mucosa-associated Gut Microbiome in Healthy Individuals (2018) (0)
- 381 Burden of Non-Alcoholic Fatty Liver Disease in the Veterans Administration (2013) (0)
- Evaluation of Screening Approaches for Hepatocellular Carcinoma in Cirrhosis Patients from the Veteran's Affairs Health Care System (2017) (0)
- 5 Birth cohort effect and the incidence of hepatocellular carcinoma (2002) (0)
- Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality (2022) (0)
- Mo1907 Dietary Intake of Fat, Animal Products and Advanced Glycation End-Products and the Risk of Barrett's Esophagus (2013) (0)
- Mo1895 Primary Prophylaxis With Non-Selective Beta-Blockers in Patients With Cirrhosis—A Chasm Between Efficacy and Effectiveness (2015) (0)
- Sa1576 - Readmission Rates Following Gastroparesis-Related Hospitalizations in a National us Cohort (2018) (0)
- Referral and Treatment of Hepatocellular Carcinoma in United States Veterans (2011) (0)
- 869: PROGNOSIS AND CLINICAL CORRELATES OF OUTCOMES IN U.S. PATIENTS WITH INDETERMINATE PHASE CHRONIC HEPATITIS B VIRUS INFECTION (2022) (0)
- Abstract 945: Metabolic syndrome increases the risk of primary liver cancer in the United States (2011) (0)
- Su1042 Oral Bisphosphonate Use May Increase the Risk of Barrett's Esophagus: A Case-Control Study in U.S. Veterans (2013) (0)
- Tu1504 – Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 1 Infection Receiving Dialysis (2019) (0)
- Tu1050 Treatment and Outcomes of Chronic Hepatitis C (CHC) in the Elderly (2015) (0)
- Tu1628 - Risk of Bias in Systematic Reviews of Existing Systematic Reviews and Meta-Analyses of Probiotic use in Irritable Bowel Syndrome (2018) (0)
- The Risk of Hepatocellular Carcinoma in Patients with Previous Malignancy (2008) (0)
- Risk of colorectal cancer among African-American and Caucasian veterans with ulcerative colitis (2011) (0)
- 739 Outcomes of Screening for Hepatocellular Carcinoma in the United States (2009) (0)
- Mo1248 Psychosocial Interventions to Achieve Abstinence in Patients With Chronic Liver Disease and Alcohol Use Disorders: A Systematic Review (2015) (0)
- Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study (2022) (0)
- Tu1773 Gastroesophageal Malignancies in GERD Patients Undergoing Screening Endoscopy Using Automated Data: What Is the Yield and Can We Trust the Diagnostic Codes? (2013) (0)
- Sa1001 Quality of Diagnostic Processes for Hepatocellular Cancer in United States Veterans (2014) (0)
- Mo1372 Accuracy of Administrative Codes for Identifying Patients With Ulcerative Colitis and Crohn's Disease in the Veterans Affairs Health Care Systems (Vahcs) (2013) (0)
- Mo1656 TRENDS AND PROPORTIONS OF 3 CATEGORIES OF COLORECTAL CANCER DIAGNOSIS (SCREEN-DETECTED, NONADHERENCE-RELATED OR INTERVAL CRC) IN A VETERANS AFFAIRS HOSPITAL (2020) (0)
- Sa1192 THE INCIDENCE AND PREDICTORS OF DYSPLASIA WITHIN ONE YEAR OF BARRETT'S ESOPHAGUS DIAGNOSIS IN A UNITED STATES VETERANS POPULATION (2020) (0)
- Tu1495 – Real-World Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 4 Infection: Results from a Veterans Affairs Population (2019) (0)
- S0206 Association Between Common Non-Antibiotic Drugs Use and the Adherent Gut Microbiota (2020) (0)
- Interferon for postresection recurrence of hepatocellular carcinoma. (2002) (0)
- Abstract 937: Soluble receptor for advanced glycation end-products is a player in obesity-related colorectal cancer (2015) (0)
- Where did the long barrett?s esophagus go? (2002) (0)
- Mo1239 Dysplasia Detection in Surveillance Colonoscopy in a National Cohort of Veterans With Inflammatory Bowel Disease (2014) (0)
- Hepatology 2014: where are we going? (2014) (0)
- Abstract 4132: Expression of pattern recognition receptor genes and survival in colorectal adenocarcinoma (2014) (0)
- Abstract 3265: Healthy eating index 2005 and the mucosa associated gut microbiome in healthy individuals (2018) (0)
- Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection (2022) (0)
- Automated document-level classification of surveillance and diagnostic colonoscopy for Inflammatory Bowel Disease: An application of natural language processing: P-79. (2011) (0)
- Medications Altering Sex Hormone Balance and Risk of Advanced Liver Disease in HCV-infected Males: 308 (2011) (0)
- The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer. (2012) (0)
- Tu1890 – Gastric Microbiota in Helicobacter Pylori-Negative and -Positive Gastritis Among Mongolian Population (2019) (0)
- Mo1092 RISK PREDICTION MODEL FOR DETECTING GASTRIC INTESTINAL METAPLASIA IN U.S. VETERANS (2020) (0)
- 376 GENOME-WIDE ADMIXTURE MAPPING IDENTIFIES AFRICAN-SPECIFIC SUSCEPTIBILITY LOCI IN AFRICAN AMERICANS WITH CIRRHOSIS (2020) (0)
- Mo1121 Fat Mass by Bioelectrical Impedance Analysis Is Not Associated With Increased Risk of Barrett's Esophagus (2013) (0)
- Su1420 Barriers to Hepatitis C Treatment for the Veteran Population in the DAA Era (2016) (0)
- The Incidence and Prevalence of Inflammatory Bowel Disease Among Veterans: A National Cohort Study: 1290 (2011) (0)
- W1773 State of Treatment for Hepatocellular Carcinoma in Patients with HCV Infection in the Department of Veterans Affairs (2009) (0)
- Tu1129 Gluteofemoral Obesity Is Associated With a Reduced Risk of Barrett's Esophagus in Men: A Pooled Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium (2016) (0)
- 575: INTERPLAY BETWEEN ALCOHOL DRINKING AND METABOLIC TRAITS IN RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2022) (0)
- Mo1901 Clinical Outcomes of Hepatitis B Co-Infection in a United States Cohort With Hepatitis C (2012) (0)
- Ongoing Alcohol Consumptions Counteracts the Benefits of Sustained Virological Response in Patients with Well Compensated Hepatitis C Cirrhosis: an Observational Study. (2017) (0)
- 245 Dietary Calcium and Vitamin D Intake and Colonic Mucosa-Associated Microbiome in Healthy Individuals (2019) (0)
- Absence of Barrett's esophagus in neurologically normal children with gastroesophageal reflux disease (2001) (0)
- 1016 GI Bowel Symptom Comorbidity in Functional Dyspepsia (2014) (0)
- Human Genome Epidemiology ( HuGE ) Review Genetic Variants of Glutathione S-Transferase as Possible Risk Factors for Hepatocellular Carcinoma : A HuGE Systematic Review and Meta-Analysis (2008) (0)
- Outcome of reflux esophagitis in patients with and without fundoplication (1998) (0)
- Activated Duodenal Eosinophilia Is Associated with Dysbiosis in Functional Dyspepsia Patients (2018) (0)
- Sa363 PREVALENCE AND RISK FACTORS OF LOW ALANINE AMINOTRANSFERASE DEFINED NON-ALCOHOLIC FATTY LIVER DISEASE IN A GENERAL POPULATION, THE HUNT STUDY, NORWAY (2021) (0)
- T1002 Utilization and Outcomes of Palliative Therapy for Hepatocellular Carcinoma: A Population-Based Study in the United States (2010) (0)
- Hepatocellular carcinoma at the cutting edge of science and practice. (2010) (0)
- Perhaps PPIs are chemopreventive agents in Barrett esophagus after all (2005) (0)
- Epidemiology and Surveillance of Hepatocellular Carcinoma Blue Faery Bestows Two Awards to Fight Liver Cancer (0)
- Duodenal Eosinophilia is Associated with Early Satiety Among us Adult Patients with Functional Dyspepsia (2017) (0)
- The new board of editors for clinical gastroenterology and hepatology: our vision and plans. (2012) (0)
- Point-Counterpoint: Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma? (2022) (0)
- Reply. (2018) (0)
- Prevention of first variceal hemorrhage: Do we know the best option? Comment (2003) (0)
- Mo1496 – Trends in Cure Rates Among Medicare Insured Patients with Hepatocellular Carcinoma: A Population-Based Study (2019) (0)
- WORLD LITERATURE REVIEWS (2003) (0)
- Su1833 Colorectal Cancer Is Diagnosed Earlier After Inflammatory Bowel Disease Diagnosis in African Americans Compared to Whites: A National Cohort Study (2016) (0)
- Response to Swami et al. (2022) (0)
- Helicobacter pylori Infection. (2019) (0)
- Mo1576 DETERMINANTS OF RENTENTION IN CARE AFTER REFERRAL TO GI PSYCHOLOGIST (2020) (0)
- Sa1071 Military Sexual Trauma in Veterans With Hepatitis C: Gender-Based Prevalence and Association With Conditions That Impact Treatment Eligibility (2013) (0)
- Psychiatric and drug use disorders among veterans infected with hepatitis C virus (2001) (0)
This paper list is powered by the following services:
Other Resources About Hashem El-Serag
What Schools Are Affiliated With Hashem El-Serag?
Hashem El-Serag is affiliated with the following schools:
